PARIS (Reuters) - AIDS researchers want to expand their study of a rare group of HIV-infected people, whose immune systems naturally and mysteriously prevent the virus thriving in their bodies, to span the globe.
Studies of these "elite controllers", which aim to find an AIDS vaccine, have so far concentrated on north America. But now scientists are hoping to draw in people from Asia, Africa and Latin America.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
